- A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea
-
Shim J, On YK, Kwon SU, Nam GB, Lee MH, Park HW, Hong KS, Kim NH, Amarenco P, Rha SW, Shin DG, Rha JH, Kim YH
- KMID: 2517807
- Korean J Intern Med.
- 2021 Jul;36(4):906-913.
- doi: 10.3904/kjim.2020.217
Background/Aims: Atrial fibrillation (AF)-related stroke accounts for 20% of ischemic strokes. Rivaroxaban use in AF patients for preventing stroke and systemic embolism was approved in 2013 in Korea. This study... -
- CITED
-
- Close
- SHARE
-
- Close
